Skip to main content
AmigoFish

Ep. 96 – From Pharma Partnering to Biotech CEO: Sophie Kornowski on Boston Pharma’s Playbook

From The BioCentury Show · · 32 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

It took Sophie Kornowski under four years as CEO of Boston Pharma to bring it from a pipeline full of in-licensed assets to an acquisition by GSK for about $2 billion in total deal value for a single MASH program. Though her first gig as a biotech CEO, Kornowski’s success was built on her years of experience as head of partnering at Roche. She discussed that pivot and the value of rolling your sleeves up on the latest episode of The BioCentury Show.

View full story: https://www.biocentury.com/article/657446

#BiotechLeadership #DrugDevelopment #PharmaDeals #BiotechCEO #StartupSuccess #LifeSciences #MetabolicDisease #PharmaInnovation

00:00 - Introduction 01:15 - Becoming a Biotech CEO 11:40 - MASH 18:15 - First v. Best in Class 24:10 - GSK Deal

Back to The BioCentury Show · Report a problem